The minicircle is a non-viral DNA vector for non-insertional transgene expression. A typical minicircle contains a transgene expression cassette, and is free of all other plasmid DNA elements, including an antibiotic resistance gene and a plasmid DNA replication origin.
This patented invention is an internet-based laboratory data management system that can be used to create protocols, collect and organize data, archive long-term records, and facilitate scientific collaboration among researchers.
A team of Stanford researchers has developed a novel method for quickly and efficiently generating human induced pluripotent stem cells (hiPSCs) using human adipose stem cells (hASCs) as the starting population.
A team of Stanford researchers have developed a simple, novel, non-viral technique for generating human induced pluripotent stem cells (hiPSCs) with minicircle DNA. This technology uses a single minicircle vector that expresses four reprogramming factors.
This is a cell line, AC6.21, from the murine cell line of 6C3Ag^hi phenotype. The cell line supports the proliferation and differentiation of pre-B cells from their hematopoietic precursors in vitro.
Researchers in Prof. Robert Byer's laboratory have developed a new fiber laser technology for generating frequency combs with broadband output (an octave or more).
Researchers in the Ginzton lab at Stanford University have patented an all-dielectric laser-driven microstructure for producing controllable charged particle beam.
Stanford researchers have developed a highly specific, tunable system to improve the safety, efficacy and deliverability of gene therapy vectors and other biological therapies.
The transgenic biotracker mouse lines carry two or more broadly used reporters, and thus serve as sources for both labeled cells and tissues for transplantation and adoptive transfer experiments.
Stanford scientists in Dr. Liqun Luo's laboratory have developed a patented method for site-directed somatic cell recombination and concurrent labeling of "knock in" cells.
Researchers in the laboratory of Michael Cleary at Stanford University have developed a mouse that lacks the transcription factor Pbx1. Pbx1 is a proto-oncogene that was originally discovered at the site of chromosomal translocations in pediatric acute leukemia.